NUGENEREX IMMUNO-ONCOLOGY, INC.: key financial figures for fiscal year 2020 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2020)

-$1.6M

Total Assets (FY2020)

$84

Total Equity (FY2020)

-$5.8M

Source: NUGENEREX IMMUNO-ONCOLOGY, INC. 10-K filing (FY2020). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.